Cargando…
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
Autores principales: | Stevens, Natalie E., Ryan, Feargal J., Messina, Nicole L., Blake, Stephen J., Norton, Todd S., Germano, Susie, James, Jane, Eden, Georgina L., Tee, Yee C., Lynn, Miriam A., Botten, Rochelle, Barry, Simone E., Curtis, Nigel, Lynn, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471164/ https://www.ncbi.nlm.nih.gov/pubmed/37471143 http://dx.doi.org/10.1172/JCI171742 |
Ejemplares similares
-
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
por: Ryan, Feargal J., et al.
Publicado: (2023) -
Protocol to colonize gnotobiotic mice in early life and assess the impact on early life immune programming
por: Lynn, Miriam A., et al.
Publicado: (2022) -
Protocol to assess the impact of early-life antibiotic exposure on murine longevity
por: Lynn, Miriam A., et al.
Publicado: (2022) -
The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota
por: Blake, Stephen J., et al.
Publicado: (2021) -
OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice
por: Tee, Yee C., et al.
Publicado: (2021)